These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7537803)

  • 21. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
    Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
    Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
    Straub B; Müller M; Krause H; Schrader M; Miller K
    Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen.
    Jaakkola S; Vornanen T; Leinonen J; Rannikko S; Stenman UH
    Clin Chem; 1995 Feb; 41(2):182-6. PubMed ID: 7533062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reverse transcriptase-polymerase chain reaction assays for prostate cancer.
    Olsson CA; de Vries GM; Buttyan R; Katz AE
    Urol Clin North Am; 1997 May; 24(2):367-78. PubMed ID: 9126234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
    Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
    Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
    Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
    J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
    Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T
    Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
    Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
    Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.
    Zehentner BK; Secrist H; Zhang X; Hayes DC; Ostenson R; Goodman G; Xu J; Kiviat M; Kiviat N; Persing DH; Houghton RL
    Mol Diagn Ther; 2006; 10(6):397-403. PubMed ID: 17154657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
    Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
    McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
    Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hematogenous micrometastasis in patients with prostate cancer.
    Moreno JG; Croce CM; Fischer R; Monne M; Vihko P; Mulholland SG; Gomella LG
    Cancer Res; 1992 Nov; 52(21):6110-2. PubMed ID: 1382851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular staging of prostate cancer: dream or reality?
    de la Taille A; Olsson CA; Katz AE
    Oncology (Williston Park); 1999 Feb; 13(2):187-94; discussion 194-8, 204-5 pas. PubMed ID: 10079469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.
    Deguchi T; Doi T; Ehara H; Ito S; Takahashi Y; Nishino Y; Fujihiro S; Kawamura T; Komeda H; Horie M
    Cancer Res; 1993 Nov; 53(22):5350-4. PubMed ID: 7693338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
    de Cremoux P; Ravery V; Podgorniak MP; Chevillard S; Toublanc M; Thiounn N; Tatoud R; Delmas V; Calvo T; Boccon-Gibod L
    Eur Urol; 1997; 32(1):69-74. PubMed ID: 9266235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.